logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5137.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5137.produseast1
Showing 1 - 8 of 8 Items
Showing 1 - 8 of 8 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Conference Material
|
Abstract

Sequelae following an epidemic of meningococcal meningitis in Niger

Idrissa AA, Atti S, Wasaulua RK, Kazadi S, Guindo O,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
INTRODUCTION
MSF supported Niger’s Ministry of Health (MoH) in responding to a serogroup C meningococcal meningitis epidemic in Magaria and Dungass Districts in 2022. WHO’s global ro...
Conference Material
|
Slide Presentation

Sequelae following an epidemic of meningococcal meningitis in Niger

Idrissa AA, Atti S, Wasaulua RK, Kazadi S, Guindo O,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
Conference Material
|
Video

Sequelae following an epidemic of meningococcal meningitis in Niger

Coldiron ME
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
Journal Article
|
Research

Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study

Nathan N, Borel T, Djibo A, Evans D, Djibo S,  et al.
2008-04-14 • Lancet
2008-04-14 • Lancet
BACKGROUND: In sub-Saharan Africa in the 1990s, more than 600,000 people had epidemic meningococcal meningitis, of whom 10% died. The current recommended treatment by WHO is short-course...
Journal Article
|
Research

Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment

Parikh S, Newbold L, Slater S, Moschioni M, Lucidarme J,  et al.
2017-07-01 • Lancet Infectious Diseases
2017-07-01 • Lancet Infectious Diseases
BACKGROUND
The UK introduced 4CMenB-a multicomponent vaccine against serogroup B meningococcal disease-into the national infant immunisation programme in September, 2015. The Meningo...
Journal Article
|
Research

Biological diagnosis of meningococcal meningitis in the African meningitis belt: current epidemic strategy and new perspectives

Chanteau S, Rose AMC, Djibo S, Nato F, Boisier P
2007-09-03 • Vaccine
2007-09-03 • Vaccine
Laboratory diagnosis is an essential component in surveillance of meningococcal epidemics, as it can inform decision-makers of the Neisseria meningitidis serogroup(s) involved and the mo...
Journal Article
|
Research

Timely detection of meningococcal meningitis epidemics in Africa

Lewis R, Nathan N, Diarra L, Belanger F, Paquet C
2001-07-28 • Lancet
2001-07-28 • Lancet
BACKGROUND: Epidemics of meningococcal disease in Africa are commonly detected too late to prevent many cases. We assessed weekly meningitis incidence as a tool to detect epidemics in ti...
Journal Article
|
Letter

Serogroup X in meningococcal disease, Western Kenya

Materu S, Cox HS, Isaakidis P, Baruani B, Ogaro T,  et al.
2007-06-01 • Emerging Infectious Diseases
2007-06-01 • Emerging Infectious Diseases